HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

Abstract
HLA disparity has a negative impact on the outcomes of hematopoietic cell transplantation (HCT). We studied the independent impact of amino acid substitution (AAS) at peptide-binding positions 9, 99, 116, and 156, and killer immunoglobulin-like receptor binding position 77 of HLA-A, B, or C, on the risks for grade 3-4 acute graft-versus-host disease (GVHD), chronic GVHD, treatment-related mortality (TRM), relapse, and overall survival. In multivariate analysis, a mismatch at HLA-C position 116 was associated with increased risk for severe acute GVHD (hazard ratio [HR] = 1.45, 95% confidence interval [CI] = 1.15-1.82, P = .0016). Mismatch at HLA-C position 99 was associated with increased transplant-related mortality (HR = 1.37, 95% CI = 1.1-1.69, P = .0038). Mismatch at HLA-B position 9 was associated with increased chronic GVHD (HR = 2.28, 95% CI = 1.36-3.82, P = .0018). No AAS were significantly associated with outcome at HLA-A. Specific AAS pair combinations with a frequency >30 were tested for association with HCT outcomes. Cysteine to tyrosine substitution at position 99 of HLA-C was associated with increased TRM (HR = 1.78, 95% = CI 1.27-2.51, P = .0009). These results demonstrate that donor-recipient mismatch for certain peptide-binding residues of the HLA class I molecule is associated with increased risk for acute and chronic GVHD and death.
AuthorsJoseph Pidala, Tao Wang, Michael Haagenson, Stephen R Spellman, Medhat Askar, Minoo Battiwalla, Lee Ann Baxter-Lowe, Menachem Bitan, Marcelo Fernandez-Viña, Manish Gandhi, Ann A Jakubowski, Martin Maiers, Susana R Marino, Steven G E Marsh, Machteld Oudshoorn, Jeanne Palmer, Vinod K Prasad, Vijay Reddy, Olle Ringden, Wael Saber, Stella Santarone, Kirk R Schultz, Michelle Setterholm, Elizabeth Trachtenberg, E Victoria Turner, Ann E Woolfrey, Stephanie J Lee, Claudio Anasetti
JournalBlood (Blood) Vol. 122 Issue 22 Pg. 3651-8 (Nov 21 2013) ISSN: 1528-0020 [Electronic] United States
PMID23982174 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • HLA-C Antigens
  • Histocompatibility Antigens Class I
  • Receptors, KIR
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Allografts
  • Amino Acid Substitution
  • Binding Sites (genetics)
  • Child
  • Child, Preschool
  • Female
  • Graft vs Host Disease (etiology, genetics, mortality)
  • HLA-C Antigens (chemistry, genetics, metabolism)
  • Hematopoietic Stem Cell Transplantation (adverse effects, mortality)
  • Histocompatibility Antigens Class I (chemistry, genetics, metabolism)
  • Histocompatibility Testing
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Models, Molecular
  • Receptors, KIR (metabolism)
  • Risk Factors
  • Tissue Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: